Radio-responsive recA promoter significantly increases TNFα production in recombinant clostridia after 2 Gy irradiation
Open Access
- 1 August 2001
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (15) , 1197-1201
- https://doi.org/10.1038/sj.gt.3301499
Abstract
One of the major problems with gene therapy today is the lack of tumour specificity. The use of anaerobic apathogenic clostridia as a gene transfer system can target anoxic areas within the tumour. These bacteria can be genetically modified to express therapeutic proteins such as TNFα locally in the tumour. As shown in our results, ionising irradiation can be used in clostridia to activate genes encoding cytotoxic agents under control of a radiation-inducible promoter. A 44% significant increase (P < 0.05) in TNFα secretion was seen 3.5 h after a single dose of 2 Gy. A second dose of 2 Gy was also capable of repeating gene activation and gave a significant increase of TNFα production of 42% (P < 0.05). These results provide evidence that spatial and temporal control of gene expression can be achieved using a radio-inducible promoter. Repetitive gene activation was feasible with a second dose of 2 Gy, indicating that fractionated radiotherapy could lead to repeated gene induction resulting in prolonged and enhanced protein expression. Gene targeting by ionising radiation could thus provide a new means of increasing the therapeutic ratio in cancer treatment.Keywords
This publication has 23 references indexed in Scilit:
- Improvement ofClostridiumtumour targeting vectors evaluated in rat rhabdomyosarcomasFEMS Immunology & Medical Microbiology, 2001
- Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumorsCancer Gene Therapy, 2000
- Regression of Hepatocellular Carcinoma in Vitro and in Vivo by Radiosensitizing Suicide Gene Therapy under the Inducible and Spatial Control of RadiationHuman Gene Therapy, 1999
- Transgene Expression in Malignant Glioma Using a Replication-Defective Adenoviral Vector Containing theEgr-1Promoter: Activation by Ionizing Radiation or Uptake of Radioactive IododeoxyuridineHuman Gene Therapy, 1998
- Adenoviral TNF-α gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograftGene Therapy, 1998
- Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironmentGene Therapy, 1997
- Induction of the Suicide HSV–TK Gene by Activation of the Egr-1 Promoter with RadioisotopesHuman Gene Therapy, 1997
- Activation of the Radiosensitive EGR-1 Promoter Induces Expression of the Herpes Simplex Virus Thymidine Kinase Gene and Sensitivity of Human Glioma Cells to GanciclovirHuman Gene Therapy, 1995
- Gene therapy targeted by ionizing radiationInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Tumor Necrosis Factor (TNF)Science, 1985